Skip to main content
. 2001 Mar;183(6):2071–2080. doi: 10.1128/JB.183.6.2071-2080.2001

FIG. 4.

FIG. 4

Enhancement of monensin titers by either pZC32 plasmid-based expression of mutAB or addition of exogenous dl-valine. A, meaA mutant (WM2); B, WM2/pZC32; C, meaA icm mutant (WD2); D, WD2/pZC32; E, WD2 cells grown in the presence of 0.1 M dl-valine; F, WD2 cells grown with 0.8 M dl-valine.